Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy
NCT ID: NCT01998074
Last Updated: 2013-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study formula
extensively hydrolyzed rice protein formula
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
extensively hydrolyzed rice protein formula
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In whom cow's Milk Protein Allergy has been proved by a food challenge performed during the previous month
Exclusion Criteria
* Preterm infants
* Infants already fed with an extensively hydrolyzed formula with no improvement of the symptoms.
* Infants fed an amino acid based formula
* Infants who had an anaphylactic reaction in the past
2 Weeks
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitair Ziekenhuis
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Vandenplas Y, De Greef E, Hauser B; Paradice Study Group; Paradice Study Group. An extensively hydrolysed rice protein-based formula in the management of infants with cow's milk protein allergy: preliminary results after 1 month. Arch Dis Child. 2014 Oct;99(10):933-6. doi: 10.1136/archdischild-2013-304727. Epub 2014 Jun 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BUN 143201010095
Identifier Type: OTHER
Identifier Source: secondary_id
UP2010-Paradice
Identifier Type: -
Identifier Source: org_study_id